04/20/09 - 04:51 PM EDT
For investors still cringing at their IRAs, 401(k)s or taxable mutual funds and exchange-traded funds, are you ready to take a chance on the companies that have brought you so many unhappy returns?
02/16/09 - 10:49 AM EST
The regionals may not have as much recognition as the mammoth securities firms, but they won't be receiving as many unwanted headlines either.
01/26/09 - 04:43 PM EST
If Pfizer's looking for the next Lipitor, it probably hasn't found it with the acquisition of Wyeth.
10/28/08 - 05:05 PM EDT
Allergan, Mentor and Medicis have struggled in the past year, but if the economy improves, share prices could, too.
08/21/08 - 01:06 PM EDT
When it comes to investing in big pharmaceutical stocks, it's hard to top this company, especially as its peers continue to suffer.
07/21/08 - 12:37 PM EDT
The company continues to wrestle with the dilemma surrounding the drugs Premarin, Prempro and Premphase. Plaintiffs' lawyers have filed approximately 5,400 lawsuits.
07/01/08 - 06:59 AM EDT
In the past five years, its stock has more than tripled, easily outperforming the S&P 500 and the Amex Index of large drug stocks. Is anyone paying attention?
06/05/08 - 01:40 PM EDT
Shares of most major generic-drugmakers have traded below the S&P 500 for the 12 months ended May 23, and that index was off nearly 10%.
04/11/08 - 06:44 AM EDT
Companies such as C.R. Bard and Becton Dickinson might not be the most glamorous names, but their slow and steady performances may win the race.
04/03/08 - 06:59 AM EDT
The companies that supply the tools needed for pharma research and development often profit no matter the success of a drug trial.